A probiotic supplement appears to clear the body of a type of bacteria that can cause serious antibiotic-resistant infections, a new study finds. More research is needed, but experts said the work could lead to a way to prevent infections with the bacteria, called Staphylococcus aureus. S. aureus usually causes skin infections, but can also…  read on >  read on >

Researchers believe they have found a link between lower bacterial diversity in the intestine’s microbiome and irritable bowel syndrome (IBS). Normally, “more than 10,000 species of microorganism live in the human intestine,” noted study co-author Dr. Jung Ok Shim, a professor of pediatric gastroenterology, hepatology, and nutrition at Korea University College of Medicine in Seoul.…  read on >  read on >

Attention-deficit/hyperactivity disorder (ADHD) may be an even bigger predictor of depression and anxiety in adulthood than autism is, a new study finds — highlighting the mental health side of the disorder. It’s known that kids and adults with ADHD often have co-existing conditions, including depression and anxiety. Research suggests that about 14% of children with…  read on >  read on >

When people undergo surgery for broken arms or legs, they are often injected with prescription blood thinners to reduce their risk of developing potentially life-threatening blood clots in their lungs and legs. But a large, new study suggests it may be time to rethink this practice. It found that aspirin may be as effective as…  read on >  read on >

As numerous U.S. states move to restrict transgender health care, a new study shows that such care can substantially improve teenagers’ mental health. The study, published in the New England Journal of Medicine, followed transgender and nonbinary teenagers who received “gender-affirming” hormones — either estrogen or testosterone — for two years. During that time, researchers…  read on >  read on >

In yet another setback for the future of HIV prevention, the only HIV vaccine in a late-stage trial has failed, study leaders announced Wednesday. Launched in 2019 as a partnership between the U.S. government and the pharmaceutical giant Janssen, the Mosaico trial was being conducted in eight European nations and the Americas, including the United…  read on >  read on >